Howard Bailey Securities’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$219K Sell
416
-30
-7% -$16.8K 0.08% 113
2026
Q1
$251K Sell
446
-326
-42% -$209K 0.1% 108
2025
Q4
$522K Sell
772
-23
-3% -$15.7K 0.21% 67
2025
Q3
$508K Sell
795
-143
-15% -$86.8K 0.14% 79
2025
Q2
$503K Buy
938
+13
+1% +$6.22K 0.16% 73
2025
Q1
$388K Sell
925
-169
-15% -$73.4K 0.13% 95
2024
Q4
$452K Buy
1,094
+198
+22% +$86.8K 0.17% 78
2024
Q3
$453K Buy
+896
New +$435K 0.17% 82

Other funds holding IDXX

Howard Bailey Securities's IDXX Position: Q2 2026 in Review

Howard Bailey Securities reduced its Idexx Laboratories (IDXX) stake by 6.7% in Q2 2026, selling an estimated $16.8K and leaving 416 shares worth $219K. The position accounts for 0.08% of the portfolio, ranked #113.

Howard Bailey Securities first reported a position in IDXX in Q3 2024 and has held it in 8 quarters since. The position peaked at $522K in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Howard Bailey Securities held 416 shares of Idexx Laboratories worth $219K as of Q2 2026.
  • Howard Bailey Securities sold 30 Idexx Laboratories shares in Q2 2026, an estimated $16.8K.
  • Idexx Laboratories made up 0.08% of Howard Bailey Securities's portfolio in Q2 2026, its #113 holding.
  • Howard Bailey Securities first reported a position in Idexx Laboratories in Q3 2024 and has held it in 8 quarters since.
  • Howard Bailey Securities's Idexx Laboratories position peaked at $522K in Q4 2025.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Howard Bailey Securities's 13F filing for Q2 2026, filed 10 Aug 2026.